The sorry saga of the statins in New Zealand--pharmacopolitics versus patient care

N Z Med J. 2003 Mar 14;116(1170):U360.
No abstract available

MeSH terms

  • Drug Industry
  • Fatty Acids, Monounsaturated / economics
  • Fatty Acids, Monounsaturated / therapeutic use
  • Fees, Pharmaceutical
  • Fluvastatin
  • Government Agencies
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Indoles / economics
  • Indoles / therapeutic use
  • Insurance Coverage
  • Insurance, Pharmaceutical Services*
  • National Health Programs / economics
  • National Health Programs / organization & administration*
  • New Zealand
  • Politics
  • Pravastatin / economics
  • Pravastatin / therapeutic use
  • Rate Setting and Review
  • Simvastatin / economics
  • Simvastatin / therapeutic use

Substances

  • Fatty Acids, Monounsaturated
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Indoles
  • Fluvastatin
  • Simvastatin
  • Pravastatin